Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 22, 2023 2:01 PM 5 min read

How Australian Cannabis Brands Can Enter Europe

by Michael Sassano Benzinga Contributor
Follow

Cannabis has long been trending as a global product, providing regional players opportunities to reach outside their home countries and expand to international markets. Australia has fantastic cannabis growers, producers, brands, and clinics, and those companies looking to stretch across the seas can follow a few easy steps to ensure success.

Where Can Australian Cannabis Companies Expand To?

One of the first steps in expanding outside of Australia is identifying your company’s target market.

Australian Cannabis Expansion To Asia: Limited Opportunities

If Asia were more open to cannabis, Australians would have a clear geographic advantage in serving those emerging markets. Thailand will likely follow a medical program that may benefit Australian brands and clinic models. There are also markets like South Korea dabbling in CBD. However, Asia as a whole has been slow to embrace cannabis and related businesses.

Exporting Australian Cannabis To Europe: A More Promising Frontier

The most promising overseas cannabis market of today is Germany. The United Kingdom, Switzerland, and Poland could also be excellent testing grounds as more European countries enter the space and follow the templates of early adopters like Germany. In fact, Germany is fast becoming the standard for other European countries looking to develop robust cannabis cultivation and manufacturing industries, as well as internal consumption models. 

Models For Australian Cannabis Expansion Into Other Markets

Whatever your place within the cannabis sphere, there is a global market for your skills. 

Australian Cannabis Cultivators Can Expand With Ease

If you are a cultivator and wish to enter the German market to show off your cannabis flower, you are in luck. Selling flower is relatively easy due to the robust distributor infrastructure. Because flower is mostly commoditized, you don’t need a large sales force to sell flower. In fact, you can sell to Germany, Poland, the UK, and others from the comfort of Australia. 

The Global Cannabis Market Is Primed For Australian Manufacturers

If you are a manufacturer, plenty of groups are looking for white labels. Most European cannabis distributors are using the same white-label companies; it is not uncommon for 15 to 20 brands to use the same manufacturer. Diversity is needed, and new manufacturers would be greatly welcomed. 

Australian cannabis manufacturing brands will need to invest in a local sales staff. Some markets, like Germany, are very competitive and require extensive sales personnel to be successful. It might be prudent to enter newer or smaller markets like the UK, Poland, and Switzerland, where one local representative would suffice. 

Global Cannabis Clinics Provide Opportunity For Australian Companies

The clinic model is sweeping Europe, with establishments in Germany, the UK, Poland, Switzerland, and others. Expanding from Australia should be relatively easy since the overall model is similar; just like in Australia, new patients are more likely to seek out clinics as opposed to general practitioners if they are interested in therapeutic cannabis. Regulatory differences, advertising, and staffing will be your main concerns. 

Good Manufacturing Processes: An Essential Certification For Expansion

Be prepared for a long process, especially if you are radiating your product and entering Germany, as a radiation license can take six months — on top of the time it takes to get your product certified. 

Cannabis Pricing In The Global Market

The European cannabis market is not as competitive as Australia in terms of cannabis pricing. 

Interestingly, for manufactured products like drops and vapes, the uninsured markets of Germany, the UK, Poland, and Australia will sell for around the same price with their local currency. So, as an example, a vape cartridge can sell for around $100, 100 pounds, and 100 euros. Watch your currency conversion as the market progresses and your company expands.

Expansion On The Horizon For Australian Cannabis Companies

As more amazing Australian cannabis groups succeed in their local markets, many will seek growth overseas. Many emerging countries will be thrilled for Australian cannabis know-how to support their local cannabis needs. As you expand, consider geographic advantages and business models, check your GMP status, and enjoy better margins as more countries enter the arena. Australian cannabis products and clinics are strong and will be well received abroad.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
AsiaCannabisEurozoneMarketsGeneralAustraliacontributors
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter

The most significant difference between the cannabis industries in Australia and Europe is that all cannabis products entering Europe must conform to pharmaceutical EU-Good Manufacturing Practice (EU-GMP) standards. Many secondary drying and packaging companies can help international cultivators get their certifications: Portugal has the most, and Germany is a close second. 

All manufacturers must conform to EU-GMP standards from the start of their process. If you are a manufacturer, you will not be able to buy your extract from Canada or South Africa (which comply with Current Good Manufacturing Processes (cGMP) and African compounding GMP regulations, respectively) and make EU-GMP-certified products, even if your facility is EU-GMP accredited. You will need all starting materials except flower to be EU-GMP-certified active pharmaceutical ingredients (APIs). Much of the manufactured product in Australia today is not EU-GMP-certified and, therefore, does not meet the global standards for sale to Europe and many other countries. 

Germany is unique in that it has a partially insured market. Flower is mostly uninsured and can range in price from 12-18 euros a gram retail and around 3-6 euros a gram wholesale. Extracts are predominantly insured. A bottle of 10:10 THC:CBD extract can retail for around 225 euros insured and 100 euros not insured, and wholesale for around 125 euros insured and 40 euros not insured. 

Comments
Loading...